Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Alzheimer’s Research UK

- PMLiVE

Study reveals gut conditions could be early sign of Parkinson’s disease

Constipation, dysphagia and IBS could be potential biomarkers of the condition

- PMLiVE

Study shows AI scans could detect Parkinson’s years before clinical presentation

OCT scans could be used by the NHS for the diagnosis of neurodegenerative diseases

- PMLiVE

NIHR and EPSRC to invest £25m for research into long-term health conditions

An estimated 14 million people in England are living with MLTC

- PMLiVE

Innovate UK awards Sano Genetics £330,000 grant for ALS study

The project will chart the psychological impacts of having a genetic predisposition to ALS

- PMLiVE

Alzheimer’s Research UK awards £370,000 to University of Exeter researchers

The grants are part of a wider £3m funding announcement that aims to accelerate effective treatments for dementia

- PMLiVE

NIHR and MRC establish UK Rare Disease Research Platform with £14m investment

The platform brings together expertise from across the UK rare disease research system

- PMLiVE

Alzheimer’s Research UK and Race Against Dementia announce £500k research pledge

The funding will allow researchers to investigate the link between air pollution and Alzheimer’s disease

- PMLiVE

Alzheimer’s Research UK welcomes government’s pledge to tackle dementia crisis

The commitments form part of a new UK-wide strategy to alleviate pressures on the health system

- PMLiVE

New research shows potential to treat kidney disease with common medicines

Acute kidney injuries cause around 20% of all emergency hospital admissions in the UK

- PMLiVE

UK Government commit £50m to motor neurone disease research

The pledged funding is being placed into the hands of researchers ‘as quickly as possible’

- PMLiVE

Alzheimer’s Research UK welcomes government’s recommitment to dementia mission

One million people are predicted to be living with dementia by 2025, increasing to 1.6 million by 2040

- PMLiVE

National trial to rapidly find treatments for severe flu this winter launched in UK

REMAP-CAP will test multiple treatments at the same time in thousands of people

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links